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Abstract.  We have identified a gene (NPI46)  encoding 
a new prolyl cis-trans isomerase within the nucleolus 
of the yeast Saccharomyces cerevisiae. The protein en- 
coded by NPI46 was originally found by us in a  search 
for proteins that recognize nuclear localization se- 
quences (NLSs) in vitro.  Thus,  NPI46 binds to affinity 
columns that contain a  wild-type histone H2B NLS 
but not a mutant H2B NLS that is incompetent for nu- 
clear localization in vivo. NPI46 has two domains, a 
highly charged NH2 terminus  similar to two other 
mammalian nucleolar proteins,  nucleolin and 
Noppl40, and a COOH terminus  with 45 % homology 
to a family of mammalian  and yeast proline isomer- 
ases.  NPI46 is capable of catalyzing the prolyl cis- 
trans isomerization of two small synthetic peptides, 
succinyl-Ala-Leu-Pro-Phe-p-nitroanilide and succinyl- 
Ala-Ala-Pro-Phe-p-nitroanilide,  as measured by a 
chymotrypsin-coupled spectrophotometric assay.  By 
indirect immunofluorescence we have shown that 
NPI46 is a nucleolar protein.  NPI46 is not essential 
for cell viability. 
ARLY experiments on the folding of ribonuclease A in 
vitro suggested that all the information  necessary for 
proper  protein  folding  resides  within  the  nascent 
polypeptide chain (Anfiusen, 1973). Therefore, it was thought 
that protein folding, unlike most cellular processes, is spon- 
taneous and does not need to be catalyzed by other proteins. 
However, based on the peptide-binding  affinity of two mem- 
bers of the hsp70 family, BiP and hsc70, Rothman and col- 
leagues have proposed a different model whereby catalysts 
can determine the nature of protein folding in vivo (Flynn 
et al., 1989). Thus, families of  proteins known as chaperones 
and  two enzymes,  protein  disulfide  isomerase (PDI)  and 
peptidyl-prolyl  cis-trans isomerase  or  proline  isomerase 
(PPI), are thought to play a role in a protein reaching its final 
conformational  state  (Stamnes  et al.,  1992;  Gething  and 
Sambrook,  1992). 
Proline  isomerases belong to an abundant  class of en- 
zymes that catalyze the cis-trans isomerization  of  X-Pro pep- 
tide  bonds  and  can  accelerate  the  refolding  of proline- 
containing  polypeptides in vitro and in vivo (Gething  and 
Sambrook,  1992; Heitman et al.,  1992).  This activity has 
led investigators  to propose that these enzymes may be im- 
portant in the folding of cellular proteins in vivo. As men- 
tioned above, even though proteins can reach their final con- 
formational  state in vitro without the aid of catalysts, in vivo 
the isomerization  of the peptidyl-prolyl bond may be a rate 
limiting  step in determining  protein folding (Schmid et al., 
1986; Brandts et al., 1975). Indeed, a few examples exist that 
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support the notion that proline isomerases play a role in pro- 
tein folding in vivo (HeRman et al.,  1992). As pointed out 
in a review by Stanmes et al. (1992), even a modest increase 
in the isomerization  of the peptidyl-prolyl bond could be of 
considerable biological importance because the rate of fold- 
ing  of a particular protein within  the cell would increase 
(Stamnes et al.,  1992). 
Proline isomerases are widely distributed, and they have 
been identified in bacteria (Liu and Walsh,  1990; Hayano et 
al.,  1991; Wiilfing et al.,  1994; Roof et al.,  1994), as well 
as in a variety of tissues in different organisms (see review 
by Gething and Sambrook, 1992). These enzymes were first 
discovered by their ability to bind to drugs that cause inhibi- 
tion of T lymphocyte activation  (Heitman et al.,  1992). On 
this basis, two classes of enzymes have been identified  that 
have prolyl cis-trans isomerase activity. However, they have 
no structural  or sequence homology.  One class binds the 
immunosuppressant  drug  cyclosporin  A  (CsA) I  and  are 
known as cyclophilins,  while the second class binds the im- 
munosuppressant drugs rapamycin or FK506 and are known 
as FKBP or rapamycin-binding  proteins  (Heitman  et al., 
1992; Stamnes et al.,  1992). 
Investigators  have demonstrated that inhibition  of T cell 
activation by immunosuppressant drugs is not a result of inhi- 
bition of the isomerase activity of cyclophilins or FKBPs. In- 
stead, the drug-proline isomerase complex acts dominantly 
in a different pathway to inhibit a cellular target and some- 
1. Abbreviatiom used in this  paper: ADH, alcohol dehydrogenase; CsA, cy- 
closporin A; DAPI, 4,6-diamidino-2-phenylindole;  FKBP, FK506-binding 
protein; GST, glutathione-S-transferase;  HA, hemngglutinin; NLS, nuclear 
localization sequence. 
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Tropschug et al., 1989; Koser et al., 1991). For example, the 
CsA and FK506 toxicity is caused by the inhibition  of a 
serine-threonine  phosphatase, known as calcineurin  (Heit- 
man et al., 1991). In one instance,  inhibition of this phospha- 
tase disrupts the regulation of the nuclear import of the cyto- 
plasmic subunit of the transcription  factor, NF-AT, required 
for expression of genes involved in T cell activation  (Flana- 
gan et al., 1991). Complexes formed between proline isom- 
erases and rapamycin inhibit a different cellular target mole- 
cule than the complex formed between proline isomerases 
and cyclosporin  A or FK506 (Heitman  et al.,  1992). 
Although  some  of the  targets  of the  proline  isomer- 
ase-CsA and  FK506 drug complexes  have been identified 
and their role in inhibiting  the signal transduction pathway 
involved in T cell activation has been shown, little is known 
about  the  function  of these  enzymes  in  normal  cellular 
processes. If cellular location is any indication  of the func- 
tion of proline  isomerases,  they undoubtedly will act on 
different substrates because they are found in the cytoplasm, 
rough  endoplasmic reticulum,  mitochondria,  and the nu- 
cleus (Gething and Sambrook, 1992; Heitman et al., 1992). 
In the yeast, Saccharomyces cerevisiae, four cyclophilins 
and two FKBPs have been identified and cloned (for review 
see Heitman et al.,  1992). In this manuscript, we describe 
a novel FKBP-type proline isomerase that contains a highly 
charged  NH2-terminal  domain not present in other known 
proline isomerases, and which is located within the nucleo- 
lus. The protein was identified by us as a nuclear localization 
signal  (NLS)-binding  protein,  and  it  is  capable  of spe- 
cifically recognizing  a wild-type but not a mutant NLS by 
affinity  chromatography.  The  NH2 terminus  of NPI46  is 
highly acidic, containing  multiple potential  casein kinase II 
sites,  and is homologous to the NH2 terminus of Noppl40 
and nucleolin,  proteins suggested to be involved in the nu- 
clear import of proteins required for ribosome biogenesis 
(Meier and Blobel, 1992; Lapeyre et al.,  1987).  Our data 
show that the activity of the nucleolar proline isomerase is 
low  when  compared  to  cytoplasmic  proline  isomerase 
FKBP12 (lacking an acidic NH2 terminus),  suggesting pos- 
sible regulation  of the enzyme activity by its NH2 terminus. 
Materials and Methods 
Plasmids 
pXS4:  A  4.6-kb XbaI fragment was  excised  from a positive clone of a 
YCp50 yeast genomic library that contains the entire NPI46 gene, and was 
subcloned into the XbaI site in pBluescript SK(-). The 5' end of the gene 
is toward the BamHI site in the vector. 
pXS5:  A  1.5-kb SpeI fragment from pXS4 including the entire coding 
region of NP146 was cloned into the SpeI site in pBluescript SK(-). A ClaI 
to EcoRI DNA fragment corresponding to amino acid residues 43-275 of 
the NPI46 protein was replaced by the yeast selectable marker LEU2. 
pXS6: A 168-bp fragment was synthesized by the polymerase chain reac- 
tion. This contains nucleotides -26 to +142 of the NPI46 gene.  A BamHI 
site was engineered at the -20 position in the primer for the polymerase 
chain reaction, and the fragment was cloned into pBluescript SK(-) be- 
tween the BamHl and Clal sites.  A  1.1-kb ClaI-SspI fragment containing 
the NPI46 gene from position 126 to the end was cloned between ClaI and 
HinclI sites of the above plasmid. This recreated the entire NP146gene with 
a BamHI site at its 5' end. 
pXS7: The ends ofa 1.3-kb BamHI-Xhol fragment from pXS6 including 
the entire NPI46 coding region were filled in with Klenow and ligated into 
a previously constructed yeast centromeric plasmid pZX1 (Xue et al., 1993) 
that had been cut with HindIII and the ends filled  in with Klenow. The 
resulting  plasmid contains the yeast selectable marker URA3  with the NPI46 
gene under control of the inducible GALl0 promoter. 
pXS8:  The same BamHI-XhoI fragment as above was cloned into the 
Sinai site in pAD5  (Field et al.,  1988) that contains the yeast selectable 
marker LEU2 and the yeast alcohol dehydrogenase  (ADH) promoter,  fol- 
lowed by an epitope from the influenza hemagglufinin (HA) protein. The 
NP146  gene was fused in frame behind the HA epitope and was placed under 
control of the constitutive yeast ADH promoter. 
pXS9: A BamHI fragment containing the ADH promoter and the HA 
epitope, as well as a BamHI-SacI fragment containing the NP146gene, were 
cut out from pXS8 and cloned into pZX1 between the BamHI and Sad sites. 
The resulting plasmid expresses an HA epitope-NPI46 fusion protein under 
the control of the yeast ADH promoter.  The HA epitope is a 9-amino acid 
sequence (YPYDVPDYA) from the hemagglutinin of the influenza virus 
(HA1) that is recognized by the monoclonal anti-HA antibody 12C.A5 and 
a polyclonai  anti-HA antiserum. 
pXS10: The ADH promoter and the HA epitope were cut out from pXS8 
with BamHI and cloned into yeast centromeric plasmid pRS316 (Sikorski 
and Hieter,  1989) at the BamHI site. 
pXS11: The XhoI ends ofa BamHI-XhoI fragment from pXS6 containing 
the entire NPI46 gene were filled in with Klenow and cloned into pGEX- 
FLA (a gift from Dr. Jack D. Keene,  Duke University,  Durham, NC; see 
Hoifman et al.,  1991) between the BamHI and Klenow-filled EcoRI ends. 
This created an in frame fusion of glutathione-S-transferase (GST)  and 
NPI46 with a thrombin cleavage site in between, and put the fusion protein 
under the control of the isoprylthiogalactoside-inducible  tac promoter. 
pXSI2:  Both ends of a 4.9-kb BamHI-EcoRI fragment of pGEX-FLA 
were  filled  with  Klenow  and  religated.  This  plasmid  expresses  the 
glutathione-S-transferase  under the control of the tac promoter. 
Strains 
Escherichia cold strain XL-1 was used for all cloning.  E. coli strain BL-21 
was used for expressing proteins in bacteria. All DNA manipulations and 
bacterial transformations were  done according to published procedures 
(Sambrook et al.,  1989).  The yeast strains used were W303-1A, Mats, 
are2-1, canl-lO0, ura3-1, leu2-3,112, trpl-1, his3-11,15; WLY353, same as 
W'303-1A except nsrlA::HIS3; W303, isogenic a/c~ diploid strain; and XSY1, 
Mata,  ade2-1, canl-lO0, ura3-1, 1eu2-3,112, trpl-1, his3-11,15, npi46A:: 
LEU2. 
Yeast transformations were done using the lithium acetate method of Ito 
et al. (1983). Standard media preparation and yeast cell culture were carried 
out according to Sherman et al.  (1986). 
Chemical and Enzymes 
Succinyl-Ala-Ala-Pro-Phe-p-nitroanilide,  ot-chymotrypsin,  and bovine an- 
tithrombin were from Sigma Immunochemicals (St. Louis, MO). Succinyl- 
Ala-Leu-Pro-Phe-p-nitroanilide  was from BACHEM Bioscience Inc. (Phila- 
delphia, PA). Bovine thromhin was from ICN Biomedicais,  Inc.  (Costa 
Mesa, CA) and FKS06 was provided by Fujisawa Pharmaceuticals (Deer- 
field, IL) and Dr. Stephen Gotschlich at The Rockefeller University (New 
York).  Rapamycin  was  provided by the Drug  Synthesis  and Chemistry 
Branch, Developmental Therapeutics Program, Division of Cancer Treat- 
ment, National Cancer Institute (Bethesda,  MD). Monoclonal anti-NSRl 
antibody was a gift from Dr. John Woolford at Carnegie Mellon University 
(Pittsburgh,  PA). Monoclonal and polyclonal anti-HA antibodies were from 
BAbco (Berkeley,  CA).  FITC-conjugated  goat anti-mouse IgG and lissa- 
mine rhodamine-conjugated  donkey anti-rabbit  IgG were from Jackson Im- 
munoResearch  Laboratories, Inc.  (West Grove,  PA). 
Preparation of  a Yeast Nuclear Extract and Cytosol 
A yeast nuclear extract and cytosol were generated by the following proce- 
dure.  Yeast cells were grown in YPD medium to an OD600 of 0.8. Cells 
were harvested by centrifugation  at 5,000 rpm for 5 min. The cell pellet was 
resuspended in a minimum volume of 20 mM Tris, 2 mM EDTA, 0.5 mM 
PMSF,  1/zg/ml each of leupeptin and pepstatin. Cells were broken by vor- 
texing with glass beads.  Unbroken cells were removed by centrifugation at 
2,000 rpm for 2 rain. A crude nuclear pellet was generated by centrifugatiun 
at 14,000 rpm for 15 rain in an Eppendorf centrifuge.  The supernatant was 
further centrifuged at 100,000 rpm for 60 rain in an ultracentrifuge (TL- 
100; Beckman Instruments, Inc., Fullerton, CA) to generate a clear cyto- 
sol. The crude nuclear pellet was extracted  with 2 M NaCI,  10 mM "Iris, 
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dialyzed overnight against either 20 mM phosphate, pH 8.0, 150 mM NaCI 
(for antibody generation), or 20 mM Tris, pH 8.0 (for testing antisera), to 
generate a nuclear extract. 
AjOinity Chromatography and Antibody Preparation 
Wild-type and mutant histone H2B NLS affinity columns were prepared ac- 
cording to the procedure described in Lee et al.  (1991).  The sequence of 
the  wild-type  NLS  peptide  is  NH2-Ser-Thr-Asp-Gly-Lys-Lys3LArg-Ser  - 
Lys-Ala-Arg-Lys-Glu-Tyr-Cys-COOH, and the sequence of the mutant NLS 
peptide is the same except that Lys  31 was replaced by Met (University of 
California at Los Angeles peptide facility). 
To obtain potential NLS-binding proteins, a yeast nuclear extract and 
cytosol made from strain WLY353,  as described above, were passed over the 
wild-type NLS affinity column. The column was washed with 20 mM phos- 
phate, pH 8.0, 0.15 M  NaCI,  and eluted with 20 mM phosphate, pH 8.0, 
2 M  NaCI.  Generation of antibodies against eluant from the NLS affinity 
column (potential NLS-binding proteins) using rabbits was done essentially 
as described in Lee et al.  (1991). 
To characterize the antisera generated against the eluant from the NLS 
affinity column, a yeast nuclear extract made from yeast WLY353 was ap- 
plied to a  wild-type H2B NLS affinity column (5 ml bed volume).  The 
column was washed with 25 ml of 20 mM Tris, pH 8.0, eluted with 15 ml 
each of 0.2, 0.5, and 1 M NaC1 in 20 mM "Iris, pH 8.0. Fractions were col- 
lected, and each was precipitated with 20% trichloroacetic acid overnight 
at 4°C. The precipitated proteins were separated on a 10.5 % SDS polyacryl- 
amide gel and were transferred onto two sheets of nitrocellulose paper. One 
sheet was analyzed by immunoblotting with the antisera against potential 
NLS-binding  proteins  and  HRP-conjugated  goat  anti-rabbit IgG  using 
4-chloro-l-naphthoi as  color reagent.  The other sheet was  stained with 
India ink. 
To test the NLS-binding ability of NPI46, a nuclear extract was made 
from yeast XSYI carrying plasmid pXS9 (expressing HA-NPI46 fusion pro- 
tein). The extract was diluted with 20 mM "lMs, pH 8.0, to a final NaC! con- 
centration of 0.25 M, without dialyzing, and applied to a wild-type or a mu- 
tant H2B NLS affinity column (both 5 nil). The columns were washed with 
25 ml of 0.25 M  NaCl in 20 mM Tris, pH 8.0, eluted with 15 ml each of 
0.3, 0.5, and 1 M NaCI in 20 mM Tris, pH 8.0. The fractions were analyzed 
by immunoblotting with the monoclonal anti-HA antibody 12CA5 as above. 
Isolation of  NPI46 Gene 
Affinity-purified antibody was used to screen a XZAP yeast genomic expres- 
sion library (Stratagene,  La Jolla, CA; see Mngraw and Chae,  1993), as 
described in Snyder et al.  (1987).  Positive clones were used to generate 
probes to screen a YCp50 yeast genomic library (a gift from Mark Rose, 
Princeton University, Princeton, NJ) using the colony hybridization method 
(Sambrook et al., 1989). Unidirectional nested deletions of pXS4 were per- 
formed in both orientations using exonuclease m  according to the proce- 
dure of Sambrook et al. (1989). The deletion series were transformed into 
E.  Coli XL-1. Dideoxy sequencing was carried out using a Sequenase Kit 
(U.S.  Biochemical  Corp.,  Cleveland,  OH)  according  to  the procedure 
provided by the manufacturer.  Sequence  editing and analysis were per- 
formed using the GenBank databank version 81 "FASTA' program (Pearson 
and Lipman,  1988). 
Disruption of the NPI46 Gene and Tetrad  Analysis 
One copy of the NPI46 gene on the chromosome was disrupted with a partial 
deletion (npi46A::LEU2)  by the one-step gene disruption method (Roth- 
stein,  1983).  A  linear 2.8-kb fragment from pXS5 containing the entire 
NPI46 gene, with the ClaI to EcoRI region being replaced by the yeast selec- 
table marker LEU2, was isolated and transformed into yeast strain W303. 
The LEU2 + transformants were further confirmed by Southern blot analy- 
sis. Heterozygous diploids were sporulated, and the tetrads were dissected 
and analyzed according to the procedure of Sherman et al.  (1986). 
Purification of  the GST-NPI46 Fusion Protein 
E.  Coli strain BL-21  carrying pXSll  or pXS12 were grown overnight in 
Luria broth containing ampicillin.  After a  1:10 dilution,  the cells were 
grown for an additional hour in the same medium. IPTG was then added 
to 1 mM to induce the expression of the proteins. Cells were harvested after 
a 2-h induction period and were resuspended in a minimum volume of a 
buffer containing 20 mM  phosphate,  pH  8.0,  0.15  M  NaC1,  1%  Triton 
X-100, and 0.5 mM PMSE Lysozyme was added to the suspension to a con- 
centration of 1 mg/ml, and the suspension was incubated on ice for 20 min. 
The suspension was then sonicated four times for 30 s and was centrifuged 
in an Eppendorf centrifuge at 0°C and 14,000 rpm for 30 min. The superna- 
tant was applied to a glutathione-Sepharose 4B column (Pharmacia LKB 
Biotechnology, Piscataway, NJ), and GST-NPI46 fusion protein or GST was 
purified according to Smith and Johnson (1988). 
Results 
Isolation of  a Yeast  Gene Encoding an NLS-binding 
Protein with an Apparent Molecular Mass of 70 kD 
Our laboratory had previously identified a protein in yeast, 
NSR1,  that specifically recognized NLSs in vitro (Lee and 
M~l~se,  1989;  Lee et al.,  1991). However,  it is clear from 
our analysis that although NSR1 is the major NLS-binding 
protein by this assay,  other NLS-binding proteins are also 
present in yeast (Lee et al.,  1991; Xue, Z., and T. M~l~se, 
unpublished results). The fact that NSR1 is not essential for 
yeast viability, although disruption of this gene results in a 
slow-growth phenotype,  made us  wonder if any of these 
other NLS-binding proteins had overlapping function with 
NSR1. 
To isolate additional NLS-binding proteins, we prepared 
nuclear and cytosolic extracts from a yeast strain contain- 
ing a disruption in NSRI (nsrl-h::HIS3; WLY353). Poten- 
tial  NLS-binding  proteins  were  purified  on  an  affinity 
column containing the wild-type histone H2B NLS (Lee et 
al., 1991). The eluant from the affinity column was used to 
generate antibodies (see Materials and Methods). The an- 
tiserum was tested against whole cell extracts from yeast by 
immunoblot analysis, and several protein bands were recog- 
nized by the antisera. We chose to further characterize a ma- 
jor 70-kD protein present in the immunoblots. The 70-kD 
protein band on a strip of nitrocellulose paper, correspond- 
ing to the 70-kD protein in the immunoblot, was used to 
affinity purify antiserum against this protein from the crude 
antiserum (Pringle et al.,  1989). 
To ensure that the purified anti-70-kD antiserum we ob- 
tained recognized the same 70-kD NLS-binding protein that 
we originally observed in the eluant of a  wild-type NLS 
affinity column, whole-cell extracts and yeast nuclear ex- 
tracts made from strain WLY353, as well as fractions result- 
ing from the passage of nuclear extracts over a  wild-type 
NLS affinity column, were analyzed using the purified anti- 
serum (Fig. 1). A 70-kD protein was recognized in whole-cell 
extracts, as well as in the nuclear extract (Fig.  1, Immuno- 
blot, lanes 1 and 2). When the nuclear extract was fraction- 
ated by passage over the NLS affinity column, most proteins 
were present in the flow-through, buffer wash, and 0.2-M salt 
fractions (Fig. 1, India ink, lanes 3-7). However, the 70-kD 
protein band was absent from the flow-through, buffer wash, 
and 0.2-M salt-eluted fractions, but present in the 0.5-M 
salt--eluted fraction (Fig.  1, ltwnunoblot, lanes 3-7). We con- 
clude from these results that the affinity-purified antiserum 
recognizes a potential NLS-binding protein with an apparent 
molecular mass of 70 kD. 
The purified antiserum was then used to screen a XZAP 
yeast genomic expression library. Several identical positive 
clones were isolated. The entire gene along with flanking 
regions was isolated from a  yeast plasmid library using a 
probe made from the positive clone obtained from the ex- 
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molecular mass of 70 kD by an affinity-purified  polyclonal antise- 
rum. Yeast  whole cell and nuclear extracts were made as described 
in the Materials and Methods. A nuclear extract made from strain 
WLY353 was dialyzed against 20 mM Tris, pH 8.0, overnight, and 
fractionated  on  a  wild-type  H2B  NLS  affinity  column  (see 
Materials and Methods). (Lane 1) WLY353 cells; (lane 2) nuclear 
extract from WLY353; (lane 3) flow-through  fraction from the NLS 
affinity column; (lane 4) 20 mM Tris buffer wash fraction; (lane 
5) 0.2 M NaC1 eluant; (lane 6) 0.5 M NaCI eluant; (lane 7) 1.0 M 
NaCI eluant; (lane 8) XSYI carrying pXS7 grown on galaetose me- 
dium (the expression of NPI46 is induced); (lane 9) XSY1 carrying 
pXS7 grown in glucose medium (the expression of NPI46 is re- 
pressed). The approximate positions of  the molecular mass markers 
are indicated on the left. To allow detection of proteins in atl frac- 
tions by India ink staining, the 0.2-, 0.5-, and 1.0-M NaCl eluant 
lanes were loaded with twice as much sample as the flow  through 
and buffer wash lanes. 
under the inducible yeast GALl0 promoter in plasmid pXS7, 
and  subsequently transformed into the yeast strain XSY1 
(npi46A::LEU2). Cells were grown on media containing ei- 
ther glucose or galactose as a carbon source, and whole-cell 
extracts were then made and subsequently analyzed by im- 
munoblotting. The 70-kD protein band is present in extracts 
from cells grown on galactose medium (NPI46 is induced), 
but  absent  in  ceils  grown in  glucose  medium  (NPI46 is 
repressed) (Fig.  1, Immunoblot,  lanes 8 and 9). 
All the data above demonstrate that NPI46 is indeed the 
gene encoding for p70, and that it is not essential for cell via- 
bility. The difference between the apparent molecular mass 
of NPI46 protein measured on an SDS gel (,x,70 kD) and the 
actual molecular mass calculated from the predicted amino 
acid sequence of the gene (46.5 kD) likely results from the 
highly charged nature of the NH2 terminus of the protein. 
NPI46 Binds Specifically to an Affinity Column 
Conjugated with a Peptide Containing the g/lid-type 
Histone H2B NLS 
To  test  whether  the NPI46 gene  encodes  a  protein  that 
specifically recognizes a wild-type but not a mutant NLS, we 
tested whether the protein product bound specifically to a 
wild-type NLS affinity column. A plasmid (pXS9) was con- 
structed that expresses an in-frame fusion of NPI46, and the 
HA epitope that is under the control of the constitutive ADH 
promoter. The npi46-  yeast strain XSY1  was transformed 
with this plasmid. Cells containing the plasmid were grown 
overnight on synthetic medium lacking uracil, diluted into 
YPD  medium,  and  allowed to  grow  to  an  OD~  of 0.8. 
pression library. Sequencing of the clone revealed the pres- 
ence of a long open reading frame, coding for a protein with 
411 amino acid residues, and a molecular mass of 46,541 D. 
The predicted amino acid sequence of the COOH-terminal 
106 residues share a high degree of homology with a class 
of proline isomerases that bind to  FK506 and rapamycin 
(Heitman  et  al.,  1992).  We  have  designated  this  gene, 
Nucleolar Proline Isomerase or NPI46. 
One copy of the wild-type NPI46 gene in the diploid strain 
W303 was replaced with a deletion allele (see Materials and 
Methods) using the one-step gene disruption method (Roth- 
stein,  1983). Two independent heterozygous diploids were 
sporulated,  and a total of 52 tetrads were dissected.  Four 
viable spores were recovered from each tetrad, two of them 
being LEU  +.  All four spores grew normally to form colo- 
nies  of the  same  size as  the  normal  haploid W303.  The 
npi46-  strain has no observable phenotype. We also com- 
pared the sensitivity of the npi46- and NPI46  + strains to- 
ward FK506 and rapamycin, and we found that the sensitiv- 
ity level of both strains toward either drug is identical (data 
not shown). 
Consistent with NPI46 being the gene encoding the 70-kD 
protein, the protein was absent in LEU  + colonies (contain- 
ing a disrupted copy of NP146; this strain was used for the 
experiments discussed below) and present in leu- colonies 
(containing the normal NPI46  gene; data not shown), as ana- 
lyzed in immunoblots using the affinity-purified anti-70-kD 
antibody. To further ensure that the NP146gene encoded p70, 
we checked that p70 expression coincided with transcription 
from the NPI46 gene. To do this, the NPI46 gene was placed 
Figure 2. NPI46 binds to a wild-type NLS affinity column. A nu- 
clear extract from yeast XSYI carrying plasmid pXS9 was passed 
over an affinity column conjugated with peptide containing either 
the wild-type or a mutant historic H2B NLS, as described in the 
Materials and Methods. Proteins in fractions collected from the 
column were detected by immuaoblotting or India ink staining, as 
described in Materials and Methods. The immunoblot panels (at 
and rout) show the result of immunoblotting with anti-HA mono- 
clonal antibody 12CA5; the India ink panels (at and rout) show the 
result of India ink staining, at, Samples collected from the wild- 
type H2B NLS affinity column; rout, samples collected from the 
mutant H2B NLS affinity column. (Lane 1) flow-through; (lane 2) 
0.25-M salt wash; (lane 3) 0.3-M salt elution; and (lane 4) 0.5-M 
salt elution. The arrow indicates the positon of NPI46. 
The Journal of Cell Biology,  Volume 126, 1994  856 i  ACTAGTATTAGCTCGCTGTT~TTTT~GCCCTCTAC~ACTGTCGT~TTCCTAAAGG 
61ACGGCAAAATTTAAAAGTG~TAAAA~TTTAAATTCGAAAAAAGAGCCTACT~C 
121GTTTCTATAT~TA~T~TTGTGTGAAAGTT~TACAT~TTG~GCAAG~TC~C 
181 CAGCC~TATGTCTGATTTGTTAC~CTAGCTACCTA~GTTTG~TGTTG~CCTTAT 
MSDLLPLATYSLNVEPY 
241 ACCCCGGTTC~G~TCGACGTCACGATGCCCATCACCGTTCGTATTACTATGGCTGCT 
TPVPAIDVTMPITVRITMAA 
301TTG~CCCGG~GCCATCGATG~GAG~CAAAC~TCGACTTT~G~TTATCAAAAGA 
LNPEAIDEENKPSTLRIIKR 
361 ~CCCGGACTTTG~GATGATGATTTTTTAGGTGGT~TTTTGATG~GACGAAATAGAC 
NPDFEDDDFL~DFDED~ID 
421G~G~TCCTCTGA~G~G~GA~AAAAAACCCAAAAGAAAAAG~GAGTAAA~C 
EESSEEEEEEKTQKKKKSKG 
481 ~G~CTGAAAGTGAAAGTGA~ATGATG~G~GACGATGACGAGGACGATGAGTTC 
KKAESESEDDEEDDDEDDEF 
541 C~G~TCCGTCCTTTTGACTTTGTCTCC~GCCC~TACC~TCTTT~ACTTG 
QESVLLTLSPEAQYQQSLDL 
601 ACCATTACTCCAG~G~G~GTCC~TTCATTGTCACTGGTTCTTACGCTATCTCCTTG 
TITPEEEVQFIVTGSYAISL 
661 AGCGGT~CTATGTT~GCATCCATTTGATACTCC~T~GAGTCG~TG~GACG~ 
SGNYVKHPFDTPMGVEGEDE 
721 GATG~GACGCTGA~TCTATGACAGTG~GACTACGACTTGACCCCAGATGA~ATG~ 
DEDADIYDSEDYD~TPDEDE 
781 ATTATTGGCGACGACATGGACGACTT~ATGACG~GAGG~G~G~GTTCGTATTG~ 
IIGDDMDDLDDEEE~EVRIE 
841G~GTC~G~G~GATG~G~GAT~TGAT~AG~G~G~C~G~G~G~G~ 
EVOEEDEEDNDGEEEOEEEE 
901G~G~G~CAAAAAG~G~GTT~GCCAG~CCT~GAAAAGCAAAAAGGAAAAAAAG 
EEEQKEEVKPEPKKSKKEKK 
961AGAAAGCACG~GAGAAAG~G~GAAAAGAAAGCTAAAAAAGTAAAG~GGTCG~TTC 
RKHEEKEEEKKAKKVKKVEF 
1021~G~GGACTTAGA~AGGGTCC~CAAAACCCAAAAGCAAAAAGG~C~GAT~G~T 
KKDLEEGPTKPKSKKEQDKH 
1081 AAACCAAAGAGT~TTTTGG~GGCGGCATAGT~TCG~GACCGTACTATCGGTGAT 
KPKSKVLEqqIVIEDRTIGD 
1141 GGCCCACAGGCT~GAGAGGTGCCAGAGTAGGCATGA~TACATTGGT~GTTAAAG~C 
GPOAKR~ARVGMRYIGKLKN 
1201 ~TAAAGTTTTCGA~G~C~GC~TAAACCATTTGCATTCAAACTTGGCCGTGGT 
GKVFDKNTSGKPFAFKLGRG 
1261 G~GTTATCAAA~CTG~A~TT~TG~GCC~TATGTCTGTT~TGGCG~CGTAGA 
EVIK~WD~GVA~MSVGGERR 
1321 ATCATCATTCCAG~CCATATGCCTAC~GC~GCTCTGCCAGGTATTCCTGCC~T 
IIIPAPYAYGKOALPGIPAN 
1381 TCCG~CTGACATTCGACGTTAAATT~TTTCTATGAAAAACTAGTACACGCGCTCGTAC 
SELTFDVKLVSMKN 
1441 ~ATAGATGTTTATATATATTATTCTTTTTA~T~TATTGT~CCTTCTGTATGTAAAT 
1501 CCGAAAACATTCTATTTCTTTTTAGTATCTATTGCTCTTTAT~GCTTTTCATTTTACTT 
1561 TTCTCCGCGGATGATACAAATAAAG~GCTGTGTTGTATAGAAAGAAATATAT~C~CA 
1621 A/~GCGTTATCTTCTTTCTGTTCCTATTTCACTGAGTGCTACTGGATGGTCGT~G 
1681AAA~TG~GAAATCTTCCAAAGC~T~G~TTC 
Figure 3. The nucleotide and deduced amino acid 
sequence of NPI46. The three acidic stretches are 
underlined,  and  the  region  homologous to the 
FKBPs is double underlined. These sequence data 
are available from EMBL/GenBank/DDBJ under 
accession number X79379. 
At this time, the cells were harvested, and crude nuclear and 
cytosollc fractions were made as described in Materials and 
Methods. The two fractions were analyzed by immunoblot- 
ring with both affinity-purified anti-p70 antisera and mono- 
clonal anti-HA antibody 12CA5. NPI46 was present only in 
the nuclear fraction (data not shown). 
NPI46 protein was solubilized from the nuclear fraction 
by salt extraction, and the extract was then diluted and ap- 
plied to a  wild-type or mutant histone H2B NLS affinity 
column, as described in Materials and Methods. Fractions 
collected were analyzed by immunoblotting with the anti- 
HA antibody 12CA5. As shown in Fig. 2 (wt), after passage 
over a wild-type H2B NLS affinity column, the majority of 
NPI46 remained bound to the column (as noted by its ab- 
sence in the flow-through and wash fractions; lanes 1 and 2). 
NPI46 was partially eluted when the salt concentration in the 
buffer was 0.3 M (lane 3) and fully eluted at a salt concentra- 
tion of 0.5 M  (lane 4). When the extract was passed over a 
mutant H2B NLS column all the NPI46 protein was found 
in the flow-through and wash fraction (Fig. 2; rout, 1 and 2). 
India ink staining of  the proteins in the different column frac- 
tions indicated that most proteins in the extract were not re- 
tained by either the wild-type or the mutant histone H2B 
NLS affinity column (all the lanes in this gel were loaded 
with the same amount of sample, thus the proteins in the salt 
eluted fractions are not visible by India ink staining). Thus, 
NPI46 has a higher affinity in vitro for the wild-type as op- 
posed to the mutant H2B NLS. 
The NPI46 Protein Contains a Highly Acidic NH2 
Terminus and a COOH Terminus That is Homologous 
to Proline Isomerases 
The nucleotide and deduced amino acid sequences of NPl46 
are shown in Fig. 3. Fig. 4 A shows the overall structure of the 
NPI46 protein. The NH~-terminal domain of the protein is 
highly charged, containing three separate regions of acidic 
residues  and  two  separate  regions  that  are  rich  in  basic 
residues.  Each acidic region contains  serine or threonine 
residues that are potential phosphorylation sites for casein 
kinase II. The first and second acidic regions of NPI46 are 
separated by the first of the two basic regions. The second 
basic region is located behind the third acidic region. There 
is a potential bipartite NLS in the second basic region, con- 
taining residues KKRK and KKAKK, separated by seven 
other amino acid residues (Robbins et al.,  1991). 
The NH~-terminal domain of NPI46 is similar to mam- 
malian nucleolin and Noppl40, and to a lesser degree, the 
yeast NSR1.  The charged domains share >20%  sequence 
identity with nucleolin and  Noppl40.  Aside  from the  se- 
Shan et al. NPI46 Encodes a Nucleolar Proline lsomerase  857 NPI46 
ScFPRI 
mFKBPI2 
NPI46 
ScFPRI 
mFKBPI2 
NPI46 
ScFPRI 
mFKBPI2 
300  G  G  G  G  HYTG  L  G 
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MGVQVETISPGDGRTFPKRGQTCWHYTGMLEDGKK 
FDSS  PF  F  LG  VI  GW  G  M  G  L  I 
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Figure 4. The domain structure of NPI46 and sequence homology 
between NPI46 and FKBPI2. (A) Structural features of  NPI46. The 
acidic and basic regions and the proline isomerase domain are la- 
beled in the figure. (B) Comparison of the sequences of yeast and 
mouse FKBPI2 with NPI46. Residues in bold letters are those in- 
volved in FK506 binding, as revealed by x-ray crystallography (Van 
Duyne et al., 1991). Conserved residues among known FKBPs are 
indicated in italics above the NPI46 sequence (from listings in Gen- 
Bank, version 81). 
quence homology, the nature of the arrangement of acidic 
and basic stretches, as well as the presence of  multiple poten- 
tial casein kinase II phosphorylation sites, are similar in all 
four proteins. Nucleolin, Noppl40, and NSR1 are all nucleo- 
lar proteins that like NP146, have been shown to bind NLSs 
in vitro (Lee et al., 1991; Xue et al., 1993; Meier and Blobel, 
1992). The extremely charged nature of the NH2 terminus 
most likely accounts for the discrepancy between the appar- 
ent molecular weight of NPI46, estimated from mobility on 
SDS gels, and its predicted molecular weight based on its 
DNA sequence. We also found this to be the case for NSR1 
and nucleolin (Lee et al.,  1991; Xue et al.,  1993). 
The COOH-terminal domain of the protein,  containing 
106 residues,  is homologous to a  class of prolyl cis-trans 
isomerases that bind the immunosuppressant drug FKS06. 
These enzymes are referred to as FKS06-binding proteins or 
FKBPs. Fig. 4 B shows the comparison of the NPI46 protein 
sequence with  two other FKBPs.  More than 45 %  of the 
residues in this domain are identical to yeast and mammalian 
FKBP12, including most of the residues that are conserved 
among the known FKBPs as listed in GenBank, version 81. 
Those residues that are involved in FK506 binding, as re- 
vealed by x-ray crystallography, are also conserved in NPI46 
(Van Duyne et al.,  1991). 
NPI46 Protein has Proline Isomerase Activity 
Because  of the  strong  sequence  homology  with  proline 
isomerases, we decided to test if NPI46 had proline isomer- 
ase activity. A plasmid that expressed a hybrid protein con- 
tainlng GST at the NH~ terminus followed by NPI46 at the 
COOH terminus (pXSll) was constructed under the control 
of the IPTG inducible tac promoter, pXS11 was transformed 
into E. coil strain BL21, and the expression of  the fusion pro- 
tein was induced by IPTG. The fusion protein was purified 
using the procedure described in Material and Methods. As 
a control, a plasmid that contained only GST rather than the 
Figure 5.  Purification of a  GST-NPI46 fusion protein.  A GST- 
NPI46 fusion protein and GST alone were purified as described in 
Materials and Methods. The purified proteins and proteins from 
IPTG-induced and uninduced E. coli cultures were first separated 
on a 12% SDS gel and then stained with Coomassie brilliant blue. 
(Lane 1 ) Protein profile of an uninduced culture; (lane 2) protein 
profile of an induced culture expressing the GST-NPI46 fusion pro- 
tein; (lane 3) purified GST-NPI46 fusion protein; (lane 4) purified 
fusion protein after digestion with thrombin to remove the GST 
moiety;  (lane 5) purified GST. Positions of the molecular mass 
markers are indicated on the left side. 
GST-NPI46 hybrid protein (pXS12)  was constructed. GST 
was expressed and purified identically to the fusion protein, 
using pXSl2.  Fig. 5 displays the separation of the purified 
proteins on a 12% SDS gel. Both the purified GST-NPI46 fu- 
sion protein and GST protein were tested for isomerase activ- 
ity by using a standard chymotrypsin-coupled spectrophoto- 
metric  assay  (Heitman et  al.,  1993),  as  described  in  the 
legend of Fig. 6. 
Fig. 6 A shows the results of the activity assays using 100 
#g of the purified GST-NPI46 fusion protein and  50 #M 
succinyl-Ala-Leu-Pro-Phe-p-nitroanilide  as  substrate.  In 
this assay, we observe proline isomerase activity for purified 
GST-NPI46, but not for the purified GST alone, even though 
double the amount of the protein was used. When a different 
synthetic peptide,  succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, 
was used as a substrate, the isomerase activity of  GST-NPI46 
was lower, only 15 % of that measured with the first peptide 
(data not shown). We estimate that the activity of the NPI46 
fusion protein is only "~5 % of that previously reported for 
FKBP12.  To ensure that the low isomerase activity of the 
GST-NPI46 protein was not caused by the presence of the 
GST moiety, the purified fusion protein was digested with 
thrombin  to  remove the  GST  moiety.  Antithrombin  was 
added to inactivate excess thrombin, and the isomerase ac- 
tivity of the sample was measured. The same level of activity 
was observed with both GST-NPI46 and NPI46.  Thus, the 
results indicate that GST does not interfere with the activity 
of NPI46 (data not shown). 
The isomerase activity of FKBPs is  inhibited by either 
FK506 or rapamycin. Thus, we tested the ability of these two 
drugs to inhibit the activity of NPI46.  Fig.  6 B  shows the 
results. Both rapamycin and FK506 inhibit the isomerase ac- 
tivity of NPI46 almost completely at a concentration of 1 
t~M. The concentration ofinhibitors required for 100% inhi- 
bition of activity is lower than the concentration of NPI46 
protein used in the assay. This may either result from an inac- 
curacy in the measurement of the protein concentration of 
the Lowry assay, or because some of the purified protein has 
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Figure 6. Proline isomerase activity of NPI46. (A) The isomerase 
activity of the purified GST-NPI46 fusion protein and the purified 
GST were measured according to the procedure of Heitman et al. 
(1993). Samples were assayed in a mixture containing;  50 mM 
Hepes, pH 8.0, 100 mM NaCI, 500 #g of chymotrypsin, and either 
100 #g of purified GST-NPI46 fusion protein (labeled as NPI46 in 
the figure) or 200 #g of purified GST (labeled as GST) in a l-ml 
vol. The assay mixtures were chilled to 4°C, and 10/~1 of 5 mM 
succinyl-Ala-Leu-Pro-Phe-p-nitroanilide,  dissolved  in  trifluoro- 
ethanol containing 470 mM LiC1, was added to initiate the reac- 
tion. The cis to trans isomerization was monitored by a change in 
the absorbance at 395 nm. A control sample (labeled as control) 
that contained all the ingredients except for GST-NPI46  or GST was 
also assayed. (B) Inhibition of the proline isomerase activity of 
NPI46 by rapamycin and FK506. Rapamycin or FK506 was added 
to the assay mixture containing 100/Lg of purified GST-NPI46 fu- 
sion protein to a final concentration of 1 /zM, in the absence of 
chymotrypsin. The sample was then incubated on ice for 5 min, af- 
ter which time chymotrypsin was added, and the assay was per- 
formed  identically as  in A.  Control curve:  buffer only;  NPI46 
curve:  100  /zg  GST-NPI46 fusion  protein  with  no  inhibitor; 
NPI46+FK506 curve: 1 t~M FK506 and 100/zg GST-NPI46 fusion 
protein;  NPI46+rapamycin  curve:  1 #M rapamycin and  100/zg 
GST-NPI46 fusion protein. 
its  isomerase  moiety  in  an  inactive  conformation,  even 
though the GST moiety of the protein is functional. 
NPI46 is a Nucleolar Protein 
As indicated earlier, NPI46 protein is present in the nuclear, 
but not cytosolic fraction of yeast. Analysis of the subcellu- 
lar location of  NPI46 was carried out by expression of  NPI46 
on a plasmid in a yeast strain (XSY1) disrupted in the chro- 
mosomal copy of  NPI46. The strain either harbored plasmid 
pXS9 (NPI46 fused with an HA epitope) or pXS10 (HA epi- 
tope alone). By indirect immunofluorescence, NPI46 showed 
distinct nucleolar staining (Fig. 7). In yeast, the nucleolus 
forms a crescent that lines the nuclear envelope and occupies 
a sizeable volume of the nucleus. As discussed in a previous 
paper from our laboratory, in most cases, the orientation of 
the cells will be such that the nucleolar antigen (stained by 
FITC) will not overlap the DNA  (stained by DAPI  [4,6- 
diamidino-2-phenylindole]), and because the nucleolar re- 
gion is not stained well by DAPI, the two staining patterns 
will be nearly independent (see Fig.  7).  The control cells 
show little or no FITC staining.  The observed pattern of 
nucleolar staining by NPI46 is similar to that visualized for 
NSR1  (Lee et ai.,  1991) and nucleolin (when expressed in 
yeast; see Xue et al.,  1993). To further confirm that NPI46 
is  a  nucleolar protein,  we also performed double immu- 
nofluorescence  labeling using a monoclonal antibody against 
the previously identified nucleolar protein NSR1 and a poly- 
clonal anti-HA antiserum.  The staining pattern of the two 
antibodies completely overlapped with, each other (Fig.  7, 
NPI46/NSR1). We conclude that NPI46 is a novel nucleolar 
proline isomerase. 
Discussion 
We have identified a novel prolyl cis-trans isomerase in the 
yeast, Saccharomyces cerevisiae, as the result of a search for 
proteins  that  specifically  recognize  NLSs.  NPI46  has  a 
highly charged NH2 terminus,  where presumably the rec- 
ognition of the basic NLS occurs, and a  106-amino acid 
stretch  at  the  COOH  terminus  that  contains  the  proline 
isomerase activity. Analysis by indirect immunofluorescence 
demonstrated that NPI46 is a nucleolar protein. Since the 
nucleolus is  the  site of ribosome biogenesis,  and proline 
isomerases are known to facilitate the folding of  proteins, we 
propose that NPI46 is involved in the assembly or folding of 
ribosomal proteins. 
Although proline isomerases are quite abundant,  and a 
number of them have been identified,  their physiological 
substrates  are unknown.  Interestingly, only a  few proline 
isomerases have been identified that contain two domains: an 
isomerase domain and another variable domain. Two exam- 
pies are FKBP52/60 or hsp56 from calf thymus, which as- 
sociates with the 90-kD heat shock protein and is a compo- 
nent of steroid receptor complexes (Sanchez et al.,  1990; 
Yem et al.,  1992; Tad et al.,  1986; Peattie et al.,  1992), and 
FKBP25 from human thymus, which contains putative NLSs 
and is located in the nucleus by subcellular fractionation 
(Galat et al.,  1992; Jin and Burakoff, 1993). NPI46 is the 
first yeast isomerase to have such an additional domain, and 
the first proline isomerase to be found in the nucleolus of  any 
organism. 
Yeast disrupted in the chromosomal copy of the NPI46 
gene do not have an apparent phenotype, indicating that the 
function of NPI46 is not essential for cell growth. Thus far, 
none of the identified genes encoding yeast proline isomer- 
ases  are  essential  (Heitman  et al.,  1992).  This  is  either 
caused by the fact that the cis-trans isomerization about the 
X-Pro sequences in most proteins occurs at a slow rate, even 
when this reaction is not catalyzed by a proline isomerase, 
Shan  et al. NPI46 Encodes a  Nucleolar Proline lsomerase  859 Figure 7. Indirect immunofluorescence on npi46- strain XSW1 carrying the NPI46 gene fused to the HA epitope on a plasmid under the 
control of the yeast constitutive ADH promoter, or the promoter followed by HA epitope alone. Indirect immunofluorescence was carried 
out as described by Pringle et ai. (1989). The control panel is XSY1 carrying pXSI0 (HA epitope alone); NPI46 panel is XSY1 carrying 
pXS9 (containing the NPI46 gene fused to the HA epitope). DAPI, DAPI  staining of DNA; F/TC, FITC staining using monoclonal anti-HA 
antibody 12CA5 and FITC-conjugated goat anti-mouse IgG. The NPI46/NSR1 panel shows double immunofluorescent labeling of XSYI 
carrying pXS9. Rhodam/ne, Rhodamine staining using the polyclonal anti-HA antibody and lissamine rhedamine-conjugated  donkey 
anti-rabbit  IgG; F/TU, FITC staining using a monoclonai anti-NSR1 antibody and FITC-conjugated goat anti-mouse IgG. Arrows point 
to the nucleolus region. 
or alternatively, other as yet unidentified isomerases provide 
a  functionally redundant role. 
The nucleolar proline  isomerase,  NPI46,  belongs  to  a 
small group of  known isomerases that contain domains sepa- 
rate from their isomerase domain. It is tempting and reason- 
able to speculate that the function of these additional do- 
mains is either in the regulation of isomerase activity or in 
the cellular localization of the enzyme. Proline isomerases 
that have no additional domains, like FKBP12, may act on 
any proteins present in the cytoplasm that contain an X-Pro 
bond. The addition of other domains to these enzymes may 
now allow them to interact with a higher specificity to a par- 
ticular class of proteins. Interestingly, two of the enzymes 
with additional domains,  FKBP52 and NPI46,  have much 
lower activity than FKBPl2 when assayed in vitro with a 
small peptide as the substrate (Peattie et al., 1992). A possi- 
bility is that the isomerase domain is somehow masked in 
FKBP52 and NPI46, and they only become fully active after 
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profile closer to FKBP12 and thus its activity  may not be 
regulated, although it does possess a small extra domain that 
is used to localize the isomerase within the nucleus (Jin and 
Burakoff, 1993). 
The  large  size  of the  NH2-terminal domain  of NPI46 
(,~75 % of the protein) makes it feasible that this single do- 
main could carry out both a regulatory and a localization 
function.  The NHrterminal domain of NPI46 is similar to 
that found in Noppl40, nucleolin, and to some extent, NSKI 
in both overall structure and the ability of this region to bind 
NLSs in vitro. We and other laboratories have found that un- 
like NLSs, nucleolar targeting does not occur via a specific 
consensus sequence, but rather occurs through specific bind- 
ing interactions with other proteins and/or nucleic acids. In 
the case of NSR1, the NH, terminus is one of the domains 
sufficient for the nucleolar accumulation of a hybrid protein 
(Yah and M~l~se,  1993).  There are conflicting results con- 
cerning the ability of the NH2 terminus of nucleolin  to al- 
low the accumulation of a hybrid protein in the nucleolus 
(Schmidt-Zachrnann and Nigg,  1993; Creancier et al., 1993). 
Therefore, the NH2 terminus of NPI46  is a good candidate 
for mediating  the  accumulation  of the protein within  the 
nucleolus. 
The mammalian nucleolar  proteins nucleolin,  Noppl40, 
and the yeast nucleolar proteins NSR1 and NPI46 have all 
been shown to bind NLSs and to contain NH~ termini that 
are highly charged. The diversity of the cellular functions as- 
sociated with the structural domains present in these proteins 
makes it bard to argue that they all belong  to a family of 
general  nuclear transport receptors.  However, since all of 
them are present in the nucleolus,  they could be involved 
specifically  in the import of ribosomal proteins or export of 
preribosome  particles.  Another possibility,  which we con- 
sider more likely, is that all of these proteins are involved in 
the assembly  of ribosomal proteins. 
Among the nucleolar NLS-binding proteins, nucleolin and 
NSR1 contain well-conserved  RNA-recognition motifs: nu- 
cleolin has been shown  to bind ribosomal  RNA in vitro, 
and NSRI  affects  rRNA  processing  (Herrera and Olson, 
1986;  Lee et al.,  1991). Perhaps nucleolin  and NSR1 bind 
to pre-rRNA and other nucleolar proteins at the same time, 
facilitating  the assembly  of preribosome  particles.  NPI46, 
being  a  nucleolar  proline  isomerase,  likely  catalyzes  the 
rearrangement of semifolded or assembling  ribosomal pro- 
teins, as opposed to catalyzing the initial folding of a newly 
translated nascent polypeptide  chain.  The common acidic 
NH~ terminus of NPI46, NSR1 and nucleolin is likely to be 
the domain involved in protein-protein  interactions within 
the nucleolus. Given the in vitro NLS-binding ability of  these 
proteins,  it is plausible that the protein-protein  interaction 
occurs through recognition of NLSs in vivo because most, 
if not all, of the proteins in the nucleolus have an NLS. An 
alternative possibility  is that the NLS-binding  ability  ob- 
served mimics the binding of the natural substrate, which 
may be a highly basic nucleolar protein. Identification of the 
natural substrate of NPI46 will help us understand how the 
NH2  termini  of this  and  other  similar  nucleolar  proteins 
facilitate their function within the nucleolus. 
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